Editorial Commentary
Targeting heterogeneity in atypical epidermal growth factor receptor-mutated non-small cell lung cancer: insights from CHRYSALIS-2
Translational Lung Cancer Research
2026;
15
(5)
:116
.
(31 May 2026)
Original Article
The impact of neoadjuvant chemoimmunotherapy on pulmonary function in non-small cell lung cancer patients
Translational Lung Cancer Research
2026;
15
(5)
:117
.
(31 May 2026)
Development and external validation of a multivariable nomogram for predicting severe immune checkpoint inhibitor-associated myocarditis in advanced lung cancer
Translational Lung Cancer Research
2026;
15
(5)
:118
.
(31 May 2026)
ZNF528 as a novel driver of metastasis in lung cancer: insights from single-cell transcriptomics
Translational Lung Cancer Research
2026;
15
(5)
:119
.
(31 May 2026)
Duration of systemic therapy in patients with metastatic EGFR-mutated non-small cell lung cancer and brain metastases
Translational Lung Cancer Research
2026;
15
(5)
:120
.
(31 May 2026)
Dacomitinib for EGFR-L858R-mutated non-small cell lung cancer following acquired resistance to third-generation EGFR-TKIs: a retrospective real-world study
Translational Lung Cancer Research
2026;
15
(5)
:121
.
(31 May 2026)
Dynamic changes in liver-to-spleen ratio: can it be a prognostic biomarker for chemo-immunotherapy in small cell lung cancer?
Translational Lung Cancer Research
2026;
15
(5)
:122
.
(31 May 2026)
Elevated baseline C-reactive protein predicts poorer survival in lung cancer: a 22-year retrospective cohort study
Translational Lung Cancer Research
2026;
15
(5)
:123
.
(31 May 2026)
Pleural effusion volume as a novel biomarker for prognostic and therapeutic stratification in small cell lung cancer: a translationally-focused cohort study
Translational Lung Cancer Research
2026;
15
(5)
:124
.
(31 May 2026)
Surgical strategy after neoadjuvant immunochemotherapy for central-type NSCLC: restaging-guided versus pre-treatment-guided decision-making
Translational Lung Cancer Research
2026;
15
(5)
:125
.
(31 May 2026)
Biweekly carboplatin plus nab-paclitaxel with concurrent radiotherapy followed by durvalumab consolidation for unresectable locally advanced non-small cell lung cancer: a real-world retrospective cohort study
Translational Lung Cancer Research
2026;
15
(5)
:126
.
(31 May 2026)
Gut microbiome in advanced non-small cell lung cancer: effect of chemotherapy and impact on efficacy
Translational Lung Cancer Research
2026;
15
(5)
:127
.
(31 May 2026)
Real-world outcomes of consolidative durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancer: the prognostic role of clinical frailty in the post-PACIFIC era
Translational Lung Cancer Research
2026;
15
(5)
:128
.
(31 May 2026)
Exploring the effectiveness and sequence of brain local treatment combined with thoracic surgery in non-small cell lung cancer patients with brain oligometastasis
Translational Lung Cancer Research
2026;
15
(5)
:129
.
(31 May 2026)
Comparative analysis of lung cancer risk factors between never-smokers and heavy smokers: a nationwide population-based study in Korea
Translational Lung Cancer Research
2026;
15
(5)
:130
.
(31 May 2026)
CEACAM5 as a biomarker of semi-solid, lepidic lung adenocarcinoma
Translational Lung Cancer Research
2026;
15
(5)
:131
.
(31 May 2026)
3D computed tomography airway geometry for predicting bronchoscopic accessibility in peripheral pulmonary nodules: a prospective study
Translational Lung Cancer Research
2026;
15
(5)
:132
.
(31 May 2026)
Adjuvant epidermal growth factor receptor tyrosine kinase inhibitor in resected stage N2 non-small cell lung cancer harboring EGFR mutation
Translational Lung Cancer Research
2026;
15
(5)
:133
.
(31 May 2026)
Development and validation of a nomogram for predicting overall survival in small cell lung cancer: a multicenter analysis integrating multimodal therapy and molecular pathology
Translational Lung Cancer Research
2026;
15
(5)
:134
.
(31 May 2026)
CDKN1A promotes paclitaxel resistance through mediating formation of polyploid giant cancer cells and enhancing neosis in non-small cell lung cancer
Translational Lung Cancer Research
2026;
15
(5)
:135
.
(31 May 2026)
Pulmonary ground-glass opacity associated with cystic airspace: clinicopathological features and aggressiveness
Translational Lung Cancer Research
2026;
15
(5)
:136
.
(31 May 2026)
Major histocompatibility complex II serves as a prognostic biomarker in resectable pulmonary sarcomatoid carcinoma: development of a prediction model
Translational Lung Cancer Research
2026;
15
(5)
:137
.
(31 May 2026)
Diagnostic accuracy and safety of 1.1-mm cryoprobe biopsy for peripheral pulmonary lesions with or without oversheath
Translational Lung Cancer Research
2026;
15
(5)
:138
.
(31 May 2026)
Prognostic value of ROS1 rearrangement in lung adenocarcinoma stratified by clinicopathologic and radiological features: a retrospective cohort study
Translational Lung Cancer Research
2026;
15
(5)
:139
.
(31 May 2026)
Patterns of central nervous system disease and molecular landscape in epidermal growth factor receptor exon 20 insertion mutated non-small cell carcinoma
Translational Lung Cancer Research
2026;
15
(5)
:140
.
(31 May 2026)
BTLA and PD-1 combined with radiotherapy for enhancing antitumor immune response in lung cancer via the regulation of memory B cells to promote T-cell infiltration
Translational Lung Cancer Research
2026;
15
(5)
:141
.
(31 May 2026)
Utilizing clinical features, genetic mutations, and a 14-gene molecular assay for optimizing the management of multiple primary lung cancer
Translational Lung Cancer Research
2026;
15
(5)
:142
.
(31 May 2026)
Brief Report
Long-term outcomes of ALK inhibitors in metastatic ALK-positive non-small cell lung cancer: an updated indirect comparison using reconstructed patient-level data
Translational Lung Cancer Research
2026;
15
(5)
:143
.
(31 May 2026)
Review Article
Lung cancer with EGFR PACC mutations: a practical review of available treatment options and novel therapies on the horizon
Translational Lung Cancer Research
2026;
15
(5)
:144
.
(31 May 2026)
Advances in translational lung cancer research in 2025: a narrative review
Translational Lung Cancer Research
2026;
15
(5)
:145
.
(31 May 2026)
Annual progress in transbronchial diagnosis and treatment of pulmonary malignant tumors [2025]: a narrative review
Translational Lung Cancer Research
2026;
15
(5)
:146
.
(31 May 2026)
Clinical practice review of systemic treatment in large cell neuroendocrine carcinoma
Translational Lung Cancer Research
2026;
15
(5)
:147
.
(31 May 2026)
Applying artificial intelligence to ensure high quality and equitable lung cancer screening
Translational Lung Cancer Research
2026;
15
(5)
:148
.
(31 May 2026)
Application of organoid models in basic and translational research of lung cancer: a narrative review
Translational Lung Cancer Research
2026;
15
(5)
:149
.
(31 May 2026)
The role of tumor metabolic reprogramming in acquired anti-PD-1/PD-L1 resistance
Translational Lung Cancer Research
2026;
15
(5)
:150
.
(31 May 2026)
Long-term survival and biomarkers of immunotherapy in small cell lung cancer: a systematic review
Translational Lung Cancer Research
2026;
15
(5)
:151
.
(31 May 2026)
Macrophages in lung cancer: principal factors, regulatory mechanisms, and therapeutic opportunities: a narrative review
Translational Lung Cancer Research
2026;
15
(5)
:152
.
(31 May 2026)
Study Protocol
Endostar combined with PD-1 blockade, radiotherapy, GM-CSF, and IL-2 (PRaG 2.0E) for refractory non-small cell lung cancer: a single-arm, phase II clinical trial (PRaG2.0E Study Protocol)
Translational Lung Cancer Research
2026;
15
(5)
:153
.
(31 May 2026)
Case Report
Case report: durable response to osimertinib, radiotherapy, and chemotherapy combination in advanced non-small cell lung cancer with atypical metastasis
Translational Lung Cancer Research
2026;
15
(5)
:154
.
(31 May 2026)
Pathological and molecular characterization of a four-component combined small cell lung carcinoma: a case report
Translational Lung Cancer Research
2026;
15
(5)
:155
.
(31 May 2026)
Case report: first-line lorlatinib in metastatic lung adenocarcinoma with a novel WIPF1-ALK and EML4-ALK dual fusion
Translational Lung Cancer Research
2026;
15
(5)
:156
.
(31 May 2026)
Neoadjuvant chemo-immunotherapy in a kidney transplant recipient with locally advanced non-small cell lung cancer: a case report of a therapeutic dilemma
Translational Lung Cancer Research
2026;
15
(5)
:157
.
(31 May 2026)
Distinct multiplex immunofluorescence-based immune and stromal marker expression profile of subcutaneously metastatic SMARCA4-deficient undifferentiated thoracic tumor: a case report
Translational Lung Cancer Research
2026;
15
(5)
:158
.
(31 May 2026)
Letter to the Editor
Challenges for first-line therapy in elderly patients with metastatic non-small cell lung cancer
Translational Lung Cancer Research
2026;
15
(5)
:159
.
(31 May 2026)
